期刊文献+

补肾益肺消癥方对肺纤维化上皮间质转化中瘦素相关因子的影响 被引量:3

Study on the Expression of Leptin-related Factors in Pulmonary Fibrosis Epithelial Mesenchymal Transformation Model and the Effect of Bushen Yifei Xiaozheng Formula on It
下载PDF
导出
摘要 目的:明确肺纤维化上皮-间质转化(EMT)对瘦素相关因子的影响,对瘦素加速EMT的分子机制进行初探,并观察补肾益肺消癥方对EMT过程中瘦素相关因子的作用。方法:将A549细胞根据干预手段不同分为正常组、模型组[转化生长因子-β_(1)(TGF-β_(1))]、中药组(TGF-β_(1)+补肾益肺消癥方)、尼达尼布组(TGF-β_(1)+尼达尼布),免疫荧光观察α-平滑肌肌动蛋白(α-SMA)、E-钙黏附蛋白(E-cadherin)的表达,酶联免疫吸附试验(ELISA)检测细胞上清中的瘦素水平,Western Blotting检测瘦素受体(LEPR)、过氧化物酶体增殖物激活受体γ(PPAR-γ)的蛋白含量以及STAT3的活化程度。结果:与正常组比较,模型组细胞上清中瘦素水平升高(P<0.01),中药组、尼达尼布组出现不同程度的下降(P<0.001);与正常组比较,模型组LEPR蛋白表达升高(P<0.001),PPAR-γ表达下降(P<0.05),STAT3活化水平降低,中药组、尼达尼布组LEPR蛋白表达下调(P<0.001),PPAR-γ表达上调(P<0.05),中药组STAT3活化程度与模型组比较差异无统计学意义(P>0.05),尼达尼布组与模型组比较,STAT3活化水平升高(P<0.01)。结论:EMT可促进细胞内源性肺瘦素的分泌,增加细胞表面LEPR的表达,下调与瘦素有拮抗作用的PPAR-γ的含量,减少STAT3的活化,为瘦素加速EMT进程提供物质基础。而补肾益肺消癥方则可能通过降低内源性肺瘦素分泌,减少LEPR,提高PPAR-γ的水平逆转此过程。 Objective:To clarify the effect of epithelial mesenchymal transition(EMT)on leptin-related factors in pulmonary fibrosis,explore the molecular mechanism of leptin accelerating EMT,and observe the effects of Bushen Yifei Xiaozheng Formula on leptin-related factors in the process of EMT.Methods:A549 cells were divided into a control group,a model group(TGF-β_(1)),a Chinese medicinal group(TGF-β_(1)+Bushen Yifei Xiaozheng Formula),and Nintedanib group(TGF-β_(1)+Nintedanib)according to different intervention methods.The expressions ofα-smooth muscle actin(α-SMA)and E-cadherin were observed by immunofluorescence.The leptin level in cell supernatant was detected by ELISA,and the protein content of LEPR,PPAR-γand the activation degree of STAT3 were detected by Western blot.Results:Compared with control group,leptin level in cell supernatant of model group was increased(P<0.01),and decreased in Chinese medicine group and Nintedanib group(P<0.001).Compared with control group,the expression of LEPR protein in model group was increased(P<0.001),the expression of PPAR-γwas decreased(P<0.05),the activation level of STAT3 was decreased,the expression of LEPR protein in Chinese medicine group and Nintedanib group was down-regulated(P<0.001),and the expression of PPAR-γwas up-regulated(P<0.05).The activation level of STAT3 in Chinese medicinal group was not significantly different from that in model group(P>0.05),but the activation level of STAT3 in Nintedanib group was increased compared with that in model group(P<0.01).Conclusion:This study confirmed that EMT can promote the secretion of endogenous lung leptin,increase the expression of LEPR on the cell surface,down-regulate the content of PPAR-γ,which has the antagonistic effect of leptin,and reduce the activation of STAT3,providing material basis for leptin to accelerate the process of EMT.However,Bushen Yifei Xiaozheng Formula may reverse this process by reducing endogenous leptin secretion,reducing LEPR and increasing PPAR-γlevel.
作者 金译涵 张迪 贺晋芳 郑佳昆 李金桐 张亚楠 宋洁 晏军 JIN Yihan;ZHANG Di;HE Jinfang;ZHENG Jiakun;LI Jintong;ZHANG Yanan;SONG Jie;YAN Jun(Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100700,China)
出处 《世界中医药》 CAS 2022年第1期77-81,86,共6页 World Chinese Medicine
基金 国家自然科学基金面上项目(81373589)——基于“肺络微型癥瘕”探讨补肾益肺消癥法干预Ⅱ型肺泡上皮细胞ERS的作用机制 北京中医药大学青年教师项目(2019-JYB-JS-140)——基于“肺络微型癥瘕”探讨益气活血法干预Ⅱ型肺泡上皮细胞自噬功能的作用机制。
关键词 补肾益肺消癥方 肺纤维化 上皮间质转化 瘦素 A549细胞 瘦素受体 过氧化物酶体增殖物激活受体Γ 转化生长因子-β_(1) Bushen Yifei Xiaozheng Formula Pulmonary fibrosis Epithelial mesenchymal transition Leptin A549 cell LERP PPAR-γ TGF-β_(1)
  • 相关文献

参考文献7

二级参考文献67

  • 1王慧慧,蒙艳丽,杨志敏,王晓溪,徐慧星,王伟明.地龙对肺纤维化小鼠肺组织中纤维化因子TGF-β1及α-SMA表达的影响[J].中国中药杂志,2019,44(24):5473-5478. 被引量:33
  • 2周程艳,邓家刚.黄根化学成分与药理作用的研究进展[J].广西中医学院学报,2006,9(4):90-93. 被引量:2
  • 3刘世杰.劳动卫生与职业病学//中国医学百科全书编辑委员会.中国医学百科全书.上海:上海科学技术出版社.1988:138.
  • 4Olson A L, Swigris J, Lezotte D C, et al. Mortality frompulmonary fibrosis increased in the United States from 1992-2003[J]. Am J Respir Crit Care Med, 2007 , 176(3):277-284.
  • 5McKeown S, Richter AG, 0 ' Kane C, et al. Matrixmetalloproteinase expression and abnormal lung permeability areimportant determinants of outcome in IPF [ J]. Eur Respir J,2009,33(1) :77-84.
  • 6Daniil Z,Kitsanta P, Kapotsis G,et al. CD8 + T lymphocytesin lung tissue from patients with idiopathic pulmonary fibrosis[J]. Respiratory Research, 2005,6:81.
  • 7Duan W, So T, Mehta AK, et al. Inducible CD4 + LAP+Foxp3 ~ regulatory T cells suppress allergic inflammation [ J] . J_ Immunol, 2011,187(12) :6499-6507.
  • 8Oida T, Weiner HL. TGF-p induces surface LAP expression onmurine CD4 T cells independent of Foxp3 induction [ J]. PLoSOne, 2010, 5(11) ;el5523.
  • 9Yuan SM , Wang J, Hu XN, et al. Transforming growth factor-p/Smad signaling function in the aortopathies[ J]. Rev Bras CirCardiovasc, 2011, 26(3) :393403.
  • 10Sun H, Li D, Chen S,et al. Zili inhibits transforming growthfactor-beta signaling by interacting with Smad4 [ J]. J BiolChem, 2010,285(6) :42434250.

共引文献83

同被引文献56

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部